An experimental coronavirus vaccine developed by Oxford University and drug manufacturer AstraZeneca appears to be up to 90% effective, the two partners announced Monday. The encouraging results co… ...

AstraZeneca and the University of Oxford announced Monday that late-stage trials show their COVID-19 vaccine was up to 90% effective in preventing the disease.

AstraZeneca and Oxford University have started developing a version of their coronavirus shot that targets omicron, as researchers study the efficacy of existing vaccines against the latest ...

The COVID-19 vaccine being developed by British-Swedish pharmaceutical giant AstraZeneca with the University of Oxford could be key to curbing the pandemic in many low- and middle-income countries ...

(Reuters) - AstraZeneca and Oxford University's COVID-19 vaccine is more effective when its second dose is given three months after the first, instead of six weeks, a peer-reviewed study published ...

The AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced Saturday. CNN values your feedback 1.

AstraZeneca released updated information on its COVID-19 clinical trial Wednesday evening, showing an effectiveness rate of 76% instead of the 79% rate it claimed earlier in the week.

AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as ...

Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient ...

An illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on ...

An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on ...

The AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced Saturday. CNN values your feedback 1.